Non-Hodgkin lymphomas and carrier state of viral hepatitis B and C

Journal of B.U.ON.

Volumn 18, Issue 1, 2013, Pages 239-244

  Grudeva Popova, Janet ^a   Nenova, I ^a   Mateva, N ^b   Ananoshtev, N ^c   Popov, V ^a   Atanasova, M ^a  

^a UNIVERSITY HOSPITAL ST GEORGE   (Bulgaria)

^b MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^c Comprehensive Oncology Center ^*  (Bulgaria)

Author keywords

Hepatitis B; Hepatitis C; Non Hodgkin lymphomas

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CANCER SURVIVAL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION PREVENTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PREVALENCE; REMISSION; RETROSPECTIVE STUDY; SEROLOGY; SURVIVAL RATE; VIRUS CARRIER; VIRUS REACTIVATION;

AGED; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BULGARIA; CARRIER STATE; CHI-SQUARE DISTRIBUTION; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HOSPITALS, UNIVERSITY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER FUNCTION TESTS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VIRUS ACTIVATION;

EID: 84879010884     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. De Martel C, Franceschi S. Infections and cancer: Established associations and new hypotheses. Crit Rev Oncol Hematol 2009; 70:183-194.
2. Marcucci F, Mele A. Hepatitis viruses and non-Hodgkin's lymphoma: epidemiology, mechanisms of tumorigenesis and therapeutic opportunities. Blood 2011; 117:1792-1798.
3. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
4. Ferri C, Caraciolo F, Zignego A et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Hematol 1994; 88:392-394. (Pubitemid 24318191)
5. Dal Maso L, Franceshi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006; 15:2078-2085. (Pubitemid 44877029)
6. Saadoun D, Suarez F, Lefrere F et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005; 10: 574-576.
7. Lim S, Fei G, Quek R et al. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 2007; 79: 132-137. (Pubitemid 47063256)
8. Engels E, Cho E, Jee S. Hepatitis B virus infection and risk of non-Hodgkin's lymphoma in south Korea: a cohort study. Lancet Oncol 2010; 11:827-834.
9. Chen M, Hsiao L, Chiou T et al. High prevalence of occult hepatitis B infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol 2008; 87:475-480.
10. Giordano T, Henderson L, Landgren O. Risk of non-Hodgkin's lymphoma and lympho-proliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297:2010-2017. (Pubitemid 46740353)
11. De Sanjose S, Benavente Y, Vajdic C et al. Hepatitis C and non-Hodgkin's lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008; 6:451-458. (Pubitemid 351447318)
12. Sonmez M, Bektas O, Yilmaz M et al. The relation of lymphoma and hepatitis B virus/ hepatitis C virus infections in the region of East Black Sea, Turkey. Tumori 2007; 93:536-539. (Pubitemid 351158062)
13. Teoharov P.Viral hepatitides-etiology and specific diagnostics. Nosoc Inf 2009; 6:7-24.
14. Pellicelli A, Marignani M, Zoli V et al. Hepatitis C virus-related B cell subtypes in non-Hodgkin's lymphoma. World J Hepatol 2011; 3:278-284.
15. Wang F, Xu R, Luo H et al. Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma. BMC Cancer 2008; 8:115-119.
16. Kim Y, Jeong S, Kim J et al. Chronic hepatitis B, non-Hodgkin's lymphoma and effect of prophylactic antiviral therapy. J Clin Virol 2011; 51:241-245.
17. Chen H, Lin S, Lin H et al. Hepatitis B surface antigen serore-version in a T cell lymphoma patient. J Buon, 2011; 16:374-376.
18. Hoofnagle J, Dusheiko G, Schafer D. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96:447-449. (Pubitemid 12139868)
19. Lok A, Liang R, Chiu E et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy.Report of a prospective study. Gastroenterology 1991; 100:182-188.
20. Tsutsumi Y, Kawamura T, Saitoh S et al. Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy. Leuk Lymphoma 2004; 45:627-629. (Pubitemid 38196051)